The European Journal of Health Economics

, Volume 11, Issue 4, pp 405–412

Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain

Authors

    • Department of Economic Analysis and FinancesUniversity of Castilla la Mancha (UCLM)
    • CIBERESP-CIBER in Epidemiology and Public Health
    • Facultad de Ciencias Jurídicas y Sociales de Toledo Análisis Económico y Finanzas Cobertizo de San Pedro Mártir s/n
  • Julio López-Bastida
    • Evaluation and Planning ServiceCanary Islands Health Service (SCS)
    • University Hospital Nuestra Señora de la CandelariaCanary Islands Health Service
    • CIBERESP-CIBER in Epidemiology and Public Health
  • Pedro Serrano-Aguilar
    • Evaluation and Planning ServiceCanary Islands Health Service (SCS)
    • CIBERESP-CIBER in Epidemiology and Public Health
  • Lilisbeth Perestelo-Pérez
    • Evaluation and Planning ServiceCanary Islands Health Service (SCS)
    • CIBERESP-CIBER in Epidemiology and Public Health
Original Paper

DOI: 10.1007/s10198-009-0212-z

Cite this article as:
Oliva-Moreno, J., López-Bastida, J., Serrano-Aguilar, P. et al. Eur J Health Econ (2010) 11: 405. doi:10.1007/s10198-009-0212-z

Abstract

The aims of this study were to estimate medical expenditures on human immunodeficiency virus (HIV) treatment and to identify significant associated variables. We performed a retrospective multi-centre study in the Canary Islands using a sample of 569 patients recruited at outpatient visits. The study examined demographic and clinical variables, health-related quality of life (HRQOL), and health care resources. Clinical data was obtained from medical records and patient interviews. Several empirical models for identifying the relationship between health care costs and independent variables were developed. The greatest expense came from pharmaceutical expenditure (82.1% of direct costs), while hospital costs only represented 4.6% of total expenditure. The data showed a statistically significant association between health care costs and the CD4 count of the previous year. HRQOL was also a significant variable. Therefore, CD4 cell count can be used to predict health care costs in patients. Policymakers could use this information to help guide their decisions in allocating limited health care resources to HIV treatments.

Keywords

HIV/AIDSHealth care costsHealth-related quality of lifeObservational multi-centre study

Copyright information

© Springer-Verlag 2009